| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Lloyd Doggett TX37 | 7 | +$56.0K | Bought Sep 8, 26 | |
| Thomas H. Kean Jr NJ07 | 7 | −$129.5K | Trimmed Aug 27, 26 | |
| Richard Dean Dr McCormick GA06 | 2 | 3 | −$8.0K | Sold Jul 30, 26 |
| Julie Johnson TX32 | 4 | −$32.0K | Sold Dec 18, 25 | |
| Lisa McClain MI09 | 3 | 3 | +$0 | Sold Oct 31, 25 |
| Jared Moskowitz FL23 | 2 | −$16.0K | Trimmed Oct 10, 25 | |
| Valerie Hoyle OR04 | 1 | 1 | +$0 | Sold Sep 23, 25 |
| Kelly Louise Morrison MN03 | 1 | −$8.0K | Trimmed Aug 19, 25 | |
| Scott Scott Franklin FL18 | 1 | 1 | −$24.5K | Sold Jun 16, 25 |
| Pete Sessions TX17 | 1 | −$32.5K | Sold Jun 12, 25 | |
| Gilbert Cisneros CA31 | 2 | 2 | +$49.0K | Bought May 30, 25 |
| Jefferson Shreve IN06 | 2 | 1 | −$10.0K | Sold May 12, 25 |
| Marjorie Taylor Greene GA14 | 4 | +$32.0K | Bought May 5, 25 | |
| Bruce Westerman AR04 | 1 | 1 | +$0 | Sold Apr 21, 25 |
| Josh Gottheimer NJ05 | 4 | 2 | +$16.0K | Trimmed Apr 9, 25 |
| Rob Bresnahan PA08 | 1 | −$8.0K | Sold Apr 8, 25 | |
| George Whitesides CA27 | 1 | −$175.0K | Sold Mar 24, 25 | |
| Sheri Biggs SC03 | 1 | −$32.5K | Sold Mar 19, 25 | |
| Kevin Hern OK01 | 1 | −$175.0K | Sold Dec 31, 24 | |
| Virginia Foxx NC05 | 1 | +$8.0K | Bought Dec 6, 24 | |
| Ritchie John Torres NY15 | 1 | +$8.0K | Bought Sep 26, 24 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Sep 8, 26 | Lloyd Doggett TX37 | Self | Buy | $1,001 - $15,000 | Oct 5, 26 (27d) | |
| Aug 27, 26 | Thomas H. Kean Jr NJ07 | Self | Sell (part) | $1,001 - $15,000 | Sep 12, 26 (16d) | |
| Jul 30, 26 | Richard Dean Dr McCormick GA06 | Self | Sell | $1,001 - $15,000 | Aug 14, 26 (15d) | |
| Jun 29, 26 | Thomas H. Kean Jr NJ07 | Self | Sell (part) | $1,001 - $15,000 | Jul 15, 26 (16d) | |
| Jun 9, 26 | Lloyd Doggett TX37 | Self | Buy | $1,001 - $15,000 | Jul 6, 26 (27d) | |
| Jun 2, 26 | Thomas H. Kean Jr NJ07 | Self | Sell (part) | $1,001 - $15,000 | Jul 15, 26 (43d) | |
| Mar 26, 26 | Thomas H. Kean Jr NJ07 | Self | Sell (part) | $1,001 - $15,000 | Apr 13, 26 (18d) | |
| Mar 19, 26 | Richard Dean Dr McCormick GA06 | Self | Sell (part) | $1,001 - $15,000 | Apr 7, 26 (19d) | |
| Mar 19, 26 | Richard Dean Dr McCormick GA06 | Self | Sell (part) | $1,001 - $15,000 | Apr 7, 26 (19d) | |
| Mar 10, 26 | Lloyd Doggett TX37 | Self | Buy | $1,001 - $15,000 | Apr 6, 26 (27d) | |
| Jan 23, 26 | Thomas H. Kean Jr NJ07 | Self | Sell (part) | $15,001 - $50,000 | Feb 19, 26 (27d) | |
| Dec 18, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | Jan 15, 26 (28d) | |
| Dec 9, 25 | Lloyd Doggett TX37 | Self | Buy | $1,001 - $15,000 | Jan 2, 26 (24d) | |
| Nov 20, 25 | Thomas H. Kean Jr NJ07 | Self | Sell (part) | $15,001 - $50,000 | Dec 19, 25 (29d) | |
| Nov 13, 25 | Julie Johnson TX32 | Joint | Sell (part) | $1,001 - $15,000 | Dec 11, 25 (28d) | |
| Nov 5, 25 | Richard Dean Dr McCormick GA06 | Self | Buy | $1,001 - $15,000 | Dec 9, 25 (34d) | |
| Oct 31, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Nov 21, 25 (21d) | |
| Oct 30, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Nov 21, 25 (22d) | |
| Oct 30, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Nov 21, 25 (22d) | |
| Oct 10, 25 | Jared Moskowitz FL23 | Child | Sell (part) | $1,001 - $15,000 | Nov 22, 25 (43d) | |
| Oct 10, 25 | Jared Moskowitz FL23 | Child | Sell (part) | $1,001 - $15,000 | Nov 22, 25 (43d) | |
| Sep 23, 25 | Valerie Hoyle OR04 | Spouse | Sell | $1,001 - $15,000 | Oct 10, 25 (17d) | |
| Aug 19, 25 | Kelly Louise Morrison MN03 | Self | Sell (part) | $1,001 - $15,000 | Sep 11, 25 (23d) | |
| Aug 14, 25 | Julie Johnson TX32 | Joint | Sell (part) | $1,001 - $15,000 | Sep 11, 25 (28d) | |
| Aug 4, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Sep 12, 25 (39d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Schmid TimothyOfficer | Sale at price 274.74 per share. | 33.6K | $9.23M |
| Sep 1, 2026 | Schmid TimothyOfficer | Conversion of Exercise of derivative security at price 131.94 - 151.41 per share. | 33.6K | $4.87M |
| Aug 16, 2026 | Taubert Jennifer LOfficer | Sale at price 263.36 per share. | 15K | $3.95M |
| Aug 16, 2026 | Taubert Jennifer LOfficer | Conversion of Exercise of derivative security at price 115.67 per share. | 15K | $1.74M |
| Aug 12, 2026 | Duato Joaquin BoixChief Executive Officer | Sale at price 261.00 - 262.00 per share. | 123.3K | $32.20M |
| Aug 12, 2026 | Duato Joaquin BoixChief Executive Officer | Conversion of Exercise of derivative security at price 115.67 per share. | 123.3K | $14.26M |
| Aug 5, 2026 | Forminard ElizabethOfficer | Sale at price 255.93 - 257.76 per share. | 15.9K | $4.09M |
| Aug 5, 2026 | Forminard ElizabethOfficer | Conversion of Exercise of derivative security at price 131.94 per share. | 9.3K | $1.23M |
| Aug 4, 2026 | Duato Joaquin BoixChief Executive Officer | Sale at price 258.06 - 258.74 per share. | 48.5K | $12.52M |
| Jul 19, 2026 | Broadhurst VanessaOfficer | Sale at price 251.27 per share. | 23.1K | $5.79M |
| Jul 19, 2026 | Broadhurst VanessaOfficer | Conversion of Exercise of derivative security at price 129.51 - 131.94 per share. | 23.1K | $3.01M |
| Jun 10, 2026 | Wengel Kathryn EChief Technology Officer | Sale at price 241.15 per share. | 10K | $2.41M |
| Jun 10, 2026 | Wengel Kathryn EChief Technology Officer | Conversion of Exercise of derivative security at price 115.67 per share. | 10K | $1.16M |
| Apr 30, 2026 | Reed John COfficer | — | 25.3K | — |
| Feb 26, 2026 | Decker Robert JOfficer | Sale at price 247.87 per share. | 4.1K | $1.01M |
| Feb 26, 2026 | Decker Robert JOfficer | Conversion of Exercise of derivative security at price 115.67 per share. | 4.1K | $471.36K |
| Feb 19, 2026 | Schmid TimothyOfficer | Sale at price 245.66 per share. | 1.3K | $324.76K |
| Feb 17, 2026 | Schmid TimothyOfficer | Sale at price 244.20 - 244.53 per share. | 22.6K | $5.53M |
| Feb 17, 2026 | Schmid TimothyOfficer | Conversion of Exercise of derivative security at price 115.67 - 129.51 per share. | 29.6K | $2.74M |
| Feb 16, 2026 | Wolk Joseph JChief Financial Officer | Sale at price 242.68 - 242.99 per share. | 89.7K | $21.77M |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.8 | 9.3 | -1.6 | -6.0 | -2.0 | 12.7 | 0.9 | 3.7 | -0.4 | -0.4 | +27.4% | ||
| 2025 | 5.2 | 8.5 | 0.5 | -5.7 | -0.7 | -1.6 | 7.8 | 7.5 | 4.7 | 1.9 | 9.6 | 0.0 | +43.1% |
| 2024 | 1.4 | 1.6 | -2.0 | -8.6 | 1.4 | -0.3 | 8.0 | 5.1 | -2.3 | -1.4 | -3.0 | -6.7 | −7.7% |
| 2023 | -7.5 | -6.2 | 1.1 | 5.6 | -5.3 | 6.7 | 1.2 | -3.5 | -3.7 | -4.8 | 4.3 | 1.3 | −11.3% |
| 2022 | 0.7 | -4.5 | 7.7 | 1.8 | -0.5 | -1.1 | -1.7 | -7.6 | 1.3 | 6.5 | 2.3 | -0.8 | +3.3% |
| 2021 | 3.7 | -2.9 | 3.7 | -1.0 | 4.0 | -2.7 | 4.5 | 0.5 | -6.7 | 0.9 | -4.3 | 9.7 | +8.7% |
| 2020 | 2.1 | -9.7 | -2.5 | 14.4 | -0.9 | -5.5 | 3.6 | 5.2 | -3.0 | -7.9 | 5.5 | 8.8 | +7.9% |
| 2019 | 3.1 | 2.7 | 2.3 | 1.0 | -7.1 | 6.2 | -6.5 | -1.4 | 0.8 | 2.1 | 4.1 | 6.1 | +13.0% |
| 2018 | -1.1 | -6.0 | -1.3 | -1.3 | -5.4 | 1.4 | 9.2 | 1.6 | 2.6 | 1.3 | 4.9 | -12.2 | −7.6% |
| 2017 | -1.7 | 7.9 | 1.9 | -0.9 | 3.9 | 3.2 | 0.3 | -0.3 | -1.8 | 7.2 | -0.1 | 0.3 | +21.3% |
| 2016 | 1.7 | 0.7 | 2.8 | 3.6 | 0.5 | 7.6 | 3.2 | -4.7 | -1.0 | -1.8 | -4.0 | 3.5 | +12.2% |
| 2015 | -4.2 | 2.4 | -1.9 | -1.4 | 0.9 | -2.7 | 2.8 | -6.2 | -0.7 | 8.2 | 0.2 | 1.5 | −1.8% |
| 2014 | -3.4 | 4.1 | 6.6 | 3.1 | 0.2 | 3.1 | -4.3 | 3.6 | 2.8 | 1.1 | 0.4 | -3.4 | +14.2% |
| 2013 | 5.4 | 3.0 | 7.1 | 4.5 | -1.2 | 2.0 | 8.9 | -7.6 | 0.3 | 6.8 | 2.2 | -3.2 | +30.7% |
| 2012 | 0.5 | -1.3 | 1.4 | -1.3 | -4.1 | 8.2 | 2.5 | -2.6 | 2.2 | 2.8 | -1.5 | 0.5 | +6.9% |
| 2011 | -3.4 | 2.8 | -3.6 | 10.9 | 2.4 | -1.1 | -2.6 | 1.6 | -3.2 | 1.1 | 0.5 | 1.3 | +6.0% |
| 2010 | -2.4 | 0.2 | 3.5 | -1.4 | -9.3 | 1.3 | -1.6 | -1.8 | 8.7 | 2.9 | -3.4 | 0.5 | −4.0% |
| 2009 | -3.6 | -13.3 | 5.2 | -0.5 | 5.3 | 3.0 | 7.2 | -0.7 | 0.7 | -3.0 | 6.4 | 2.5 | +7.7% |
| 2008 | -5.3 | -1.9 | 4.7 | 3.4 | -0.5 | -3.6 | 6.4 | 2.9 | -1.6 | -11.5 | -4.5 | 2.1 | −10.3% |
| 2007 | 1.2 | -5.8 | -4.2 | 6.6 | -1.5 | -2.6 | -1.8 | 2.1 | 6.3 | -0.8 | 3.9 | -1.5 | +1.0% |
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Buy / hold / sell counts